07/22/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form DEF 14A | |
07/22/2024
6:01 AM | Monopar Therapeutics (Filer)
| Form ARS | |
07/11/2024
3:30 PM | Monopar Therapeutics (Filer)
| Form PRE 14A | |
07/09/2024
3:01 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
5:20 PM | Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2024
5:22 PM | Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:07 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/02/2024
5:08 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:12 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:16 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:08 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:30 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
5:12 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:56 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:10 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:35 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
7:30 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
12:45 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
5:59 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
6:36 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:37 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:38 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:39 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:33 PM | Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:34 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
11/09/2023
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
6:35 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:36 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:37 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:30 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:31 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:32 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:34 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:16 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
